Novavax, Inc. (NVAX) Receives Average Recommendation of a oeHolda from Analysts


Complete the form below to receive the latest headlines and analysts' recommendationsfor Novavax Inc. with our free daily email newsletter: Novavax, Inc. has received an average rating of "Hold" from the twelve research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and two have given a buy recommendation to the company.



from Biotech News